Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Xencor Inc (XNCR)  
$21.29 0.93 (4.57%) as of 4:30 Wed 5/15


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 66,383,000
Market Cap: 1.41(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $16.53 - $28.72
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 2
Insider 3/6 Months : 2.6
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Xencor is a clinical-stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. Co. is developing a portfolio of clinical-stage XmAb® drug candidates from its protein engineering technology platforms. Co.'s XmAb bispecific Fc drug candidates include: Vudalimab (XmAb717), which is a bispecific antibody that targets PD-1 and CTLA-4 and for patients with metastatic castration-resistant prostate cancer and other solid tumor types; and Plamotamab, which is a bispecific antibody that targets CD20, an antigen on B-cell tumors, and CD3, an activating receptor on T cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 53 53 53
Total Buy Value $0 $1,013 $1,013 $1,013
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 1 1
Total Shares Sold 51,988 151,096 184,593 219,438
Total Sell Value $1,215,592 $3,206,005 $4,083,291 $5,152,397
Total People Sold 6 6 6 7
Total Sell Transactions 10 12 13 28
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 312
  Page 11 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Desjarlais John R Sr. V.P., Research & CSO   •       –      –    2016-01-14 4 OE $0.59 $1,022 D/D 1,733 29,056     -
   Kuch John J Vice President, Finance   •       –      –    2016-01-12 4 OE $0.59 $10,001 D/D 16,951 27,601     -
   Desjarlais John R Sr. V.P., Research & CSO   •       –      –    2016-01-04 4 AS $14.13 $15,538 D/D (1,100) 27,323     -
   Desjarlais John R Sr. V.P., Research & CSO   •       –      –    2016-01-04 4 OE $0.59 $649 D/D 1,100 28,423     -
   Kuch John J Vice President, Finance   •       –      –    2015-12-17 4 S $14.89 $71,169 D/D (4,781) 10,650     -
   Desjarlais John R Sr. V.P., Research & CSO   •       –      –    2015-12-16 4 GD $0.00 $0 D/D 100 27,323     -
   Foster Paul A Chief Medical Officer   •       –      –    2015-12-16 4 AS $15.01 $90,435 D/D (6,025) 3,602     -
   Foster Paul A Chief Medical Officer   •       –      –    2015-12-16 4 OE $0.59 $2,950 D/D 5,000 9,627     -
   Dahiyat Bassil I President and CEO   •       •      –    2015-12-15 4 A $0.00 $0 D/D 7,222 174,642     -
   Rowland Lloyd A Sr. V.P. and General Counsel   •       –      –    2015-12-15 4 A $0.00 $0 D/D 1,501 1,501     -
   Desjarlais John R Sr. V.P., Research & CSO   •       –      –    2015-12-15 4 A $0.00 $0 D/D 9,240 27,423     -
   Baracchini Edgardo Jr Chief Business Officer   •       –      –    2015-12-15 4 A $0.00 $0 D/D 4,528 4,528     -
   Stafford John S Iii Director   –       •       •   2015-12-03 4 AS $14.79 $453,819 D/D (30,000) 5,264,740     -
   Baracchini Edgardo Jr Chief Business Officer   •       –      –    2015-12-01 4 AS $15.93 $19,909 D/D (1,250) 0     -
   Baracchini Edgardo Jr Chief Business Officer   •       –      –    2015-12-01 4 OE $0.59 $738 D/D 1,250 1,250     -
   Baracchini Edgardo Jr Chief Business Officer   •       –      –    2015-11-25 4 AS $15.00 $37,500 D/D (2,500) 0     -
   Baracchini Edgardo Jr Chief Business Officer   •       –      –    2015-11-25 4 OE $0.59 $1,475 D/D 2,500 2,500     -
   Stafford John S Iii Director   –       •       •   2015-11-13 4 GA $0.00 $0 D/D 5,217,240 5,294,740     -
   Stafford John S Iii Director   –       •       •   2015-11-13 4 GD $0.00 $0 I/I 5,217,240 2,000,000     -
   Ronin Trading, Llc 10% Owner   –       –       •   2015-11-13 4 GD $0.00 $0 D/D 5,217,240 2,000,000     -
   Stafford John S Iii Director   –       •       •   2015-09-03 4 AS $17.22 $172,172 D/D (10,000) 77,500     -
   Baracchini Edgardo Jr Chief Business Officer   •       –      –    2015-09-01 4 AS $16.49 $20,613 D/D (1,250) 0     -
   Baracchini Edgardo Jr Chief Business Officer   •       –      –    2015-09-01 4 OE $0.59 $738 D/D 1,250 1,250     -
   Stafford John S Iii Director   –       •       •   2015-08-05 4 AS $22.15 $221,900 D/D (10,000) 87,500     -
   Baracchini Edgardo Jr Chief Business Officer   •       –      –    2015-08-03 4 AS $21.86 $54,649 D/D (2,500) 0     -
  312 Records found
  Previous  10  11  12  13   
  Page 11 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us